News

Walgreens Settles Dispute Over Reimbursements

BY CSA STAFF

Deerfield, Ill. Walgreens said it has resolved federal and state investigations related to disputes over Medicaid reimbursements for three drugs the company dispensed at its pharmacies.

The company has denied any wrongdoing in connection with the settlement.

Many generic drugs, including those at issue in the settlement agreement, are made as both tablets and capsules. Between 2001 and 2004, Walgreens dispensed one form of each of the generic drugs at issue instead of another form of the same drug. Federal and state regulators investigated to determine whether this practice resulted in higher Medicaid reimbursement to the company.

Walgreens believes the reimbursements it received from Medicaid were consistent with applicable regulations.

The company has agreed to pay the federal government, 42 states and Puerto Rico a total of $35 million, plus investigative costs of approximately $280,000.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Are you hiring seasonal employees this year?

View Results

Loading ... Loading ...
News

Staples issues office products ultimatum

BY CSA STAFF

FRAMINGHAM, Mass. Staples increased its bid for Corporate Express and is making it harder for shareholders to vote against its unsolicited takeover proposal.

Early Tuesday, Staples announced an increased bid for Corporate Express and confirmed that shareholders owning approximately 23.3% of Corporate Express shares have already committed their shares to Staples and agreed to vote against Corporate Express’ planned merger with Lyreco. Corporate Express, based in Amsterdam, reached a merger agreement with French office products reseller Lyreco on May 21 after Staples formally launched its buyout offer on May 19. At a price of E9.15, Staples offer represents a premium of 116 to what the company’s calls Corporate Express’ unaffected share price of E4.32 of Feb. 4. Rumors of the possible combination sent shares of Corporate Express higher by the time Staples announced its bid of E7.15 on Feb. 19. That offer amount was subsequently increased to E8, with the latest increase to E9.15 representing an effort by Staples to provide Corporate Express shareholders an offer they can’t refuse.  Corporate Express has scheduled a special meeting of shareholders for June 18 to vote on the Lyreco acquisition and Staples is urging them to reject that deal in favor of its offer.

“At our increased offer price, there is no question that Staples’ offer is the superior choice for Corporate Express shareholders,” said Ron Sargent, Staples chairman and ceo. “Staples’ offer provides certain and immediate cash value, without the significant risks found in Corporate Express’ long-term business plan, with or without Lyreco.”

Corporate Express, in a brief statement posted on its Web site, said it has noted the announcement by Staples of its increased offer. The statement said Corporate Express would carefully review the increased offer and make a further announcement in due course.

The last time Corporate Express made a similar comment in response to Staples offer it announced plans to acquire Lyreco, a deal Staples contends is fraught with execution risk for Corporate Express. Conversely, Staples points out that its acquisition of Corporate Express is relatively risk free from a regulatory standpoint. The all cash deal is already fully financed and has received antitrust clearance in the U.S. and Canada and Staples said it is confident that clearance in Europe would be granted prior to the June 18 meeting at which Corporate Express shareholders are to vote on their deal with Lyreco.

The combination of Staples and Corporate Express would create a global office products and business services powerhouse with estimated annual sales of roughly $28 billion, more than 2,000 domestic and international stores dominant position in the office products delivery business in the North American and European markets.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Are you hiring seasonal employees this year?

View Results

Loading ... Loading ...
News

Walgreens May sales up 10%

BY CSA STAFF

DEERFIELD, Ill. Walgreens reported May sales of $5.o4 billion an increase of 10% from $4.58 billion for the same month in 2007. Sales in comparable-stores rose 3.9%, while comparable-store front-end sales increased 6%.

May front-end sales were helped in part by the allergy medicine Zyrtec, which recently switched from prescription to over-the-counter status, and by strong sales of consumables.

May pharmacy sales increased 8.3%, while comparable-pharmacy sales increased 2.8%. Comparable pharmacy sales were negatively impacted by 2.1 percentage points due to generic drug introductions in the last 12 months.

Pharmacy sales accounted for 64.8% of total sales for the month.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Are you hiring seasonal employees this year?

View Results

Loading ... Loading ...